VERA - Vera Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$76.40
DETAILS
HIGH:
$95.00
LOW:
$33.00
MEDIAN:
$90.00
CONSENSUS:
$76.40
UPSIDE:
124.44%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | (0.8) | 0 | 0.3 | 0.5 |
| Gross Profit | 0 | 0 | 0 | 0.8 | 0 | (0.3) | (0.5) |
| Operating Expenses | |||||||
| R&D Expenses | 215.3 | 126.2 | 78.2 | 69.8 | 22.5 | 43.9 | 7.3 |
| SG&A Expenses | 100.2 | 41.0 | 23.8 | 21.9 | 11.9 | 3.9 | 4.4 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 315.5 | 167.2 | 102.0 | 91.7 | 34.4 | 47.8 | 11.7 |
| Operating Income | |||||||
| Operating Income | (315.5) | (167.2) | (102.0) | (90.9) | (34.4) | (48.1) | (12.0) |
| Interest Expense | 7.5 | 7.6 | 3.8 | 1.0 | 0.0 | 0.2 | 0.1 |
| Interest Income | 24.5 | 20.7 | 8.0 | 1.8 | 0.0 | 0.0 | 0.2 |
| Profitability | |||||||
| EBITDA | (291.6) | (144.4) | (92.2) | (88.9) | (32.4) | (53.0) | (11.3) |
| EBIT | (292.1) | (144.5) | (92.2) | (88.1) | (32.6) | (53.2) | (11.8) |
| Income Before Tax | (299.6) | (152.1) | (96.0) | (89.1) | (32.6) | (53.4) | (11.9) |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | (299.6) | (152.1) | (96.0) | (89.1) | (32.6) | (53.4) | (11.9) |
| Per Share Data | |||||||
| EPS (Basic) | -4.66 | -2.75 | -2.25 | -3.35 | -2.43 | -14.40 | -3.46 |
| EPS (Diluted) | -4.66 | -2.75 | -2.25 | -3.35 | -2.43 | -14.40 | -3.46 |
| Shares Outstanding | 64.2 | 55.3 | 42.7 | 26.6 | 13.4 | 3.7 | 3.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 354.7 | 92.6 | 45.7 | 43.5 | 79.7 | 53.7 | 3.2 |
| Short-Term Investments | 359.9 | 548.2 | 115.0 | 71.2 | 0 | 0 | 0 |
| Net Receivables | 3.3 | 3.8 | 0 | 0 | 0 | 0.1 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11.0 | 0.9 | 3.2 | 0.7 | 0.5 | 0.4 | 0.0 |
| Total Current Assets | 728.9 | 651.2 | 172.0 | 125.7 | 82.5 | 54.3 | 3.6 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 1.9 | 4.3 | 3.0 | 5.2 | 0 | 0 | 1.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0.0 | 0.1 | 0.9 | 0 | 0 |
| Other Non-Current Assets | 3.9 | 0.1 | 0.5 | 0.5 | 0.3 | 0.3 | 0.4 |
| Total Non-Current Assets | 5.8 | 4.5 | 3.5 | 5.7 | 1.2 | 0.3 | 1.8 |
| Total Assets | 734.7 | 655.7 | 175.5 | 131.4 | 83.7 | 54.6 | 5.4 |
| Current Liabilities | |||||||
| Account Payables | 21.9 | 7.7 | 11.1 | 12.0 | 1.4 | 0.9 | 0.3 |
| Short-Term Debt | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 31.0 | 0 | 4.8 | 0 | 0.4 | 1.0 | 0.2 |
| Total Current Liabilities | 53.5 | 25.4 | 22.3 | 25.6 | 7.7 | 2.4 | 1.1 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 76.8 | 50.7 | 49.9 | 24.8 | 4.9 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0.3 | 0.3 | 1.5 | 141.5 | 40.9 |
| Total Non-Current Liabilities | 76.8 | 53.2 | 51.6 | 28.9 | 6.5 | 141.5 | 40.9 |
| Total Liabilities | 130.2 | 78.5 | 73.9 | 54.5 | 14.2 | 143.9 | 41.9 |
| Stockholders' Equity | |||||||
| Common Stock | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (760.9) | (461.2) | (309.1) | (213.1) | (124.1) | (91.4) | (38.0) |
| Accumulated Other Comprehensive Income | 0.8 | 0.4 | 0.3 | (0.2) | 0 | 0 | 0 |
| Total Stockholders' Equity | 604.5 | 577.2 | 101.7 | 76.9 | 69.6 | (89.3) | (36.5) |
| Total Liabilities & Equity | 734.7 | 655.7 | 175.5 | 131.4 | 83.7 | 54.6 | 5.4 |
| Debt Metrics | |||||||
| Total Debt | 77.3 | 54.6 | 53.7 | 31.3 | 4.9 | 0.0 | 0.1 |
| Net Debt | (277.4) | (38.0) | 8.0 | (12.2) | (74.8) | (53.7) | (3.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (299.6) | (152.1) | (96.0) | (89.1) | (32.6) | (53.4) | (11.9) |
| Depreciation & Amortization | 0.5 | 0.1 | (4.1) | (0.8) | 0.2 | 0.3 | 0.5 |
| Stock-Based Compensation | 37.9 | 20.8 | 11.5 | 8.9 | 3.0 | 0.3 | 0.3 |
| Change in Working Capital | 23.0 | 2.7 | (5.9) | 6.7 | 3.5 | 0.1 | 0.5 |
| Other Non-Cash Items | (2.9) | (6.1) | 2.3 | 6.7 | 4.0 | 17.9 | 0.3 |
| Operating Cash Flow | (241.1) | (134.7) | (92.2) | (67.6) | (23.7) | (34.8) | (10.3) |
| Investing Activities | |||||||
| Capital Expenditure | (0.6) | (1.0) | (0.1) | (0.1) | 0 | (0.1) | (0.1) |
| Acquisitions | 0 | 0 | 0 | 0.1 | 0.8 | 0 | 0 |
| Purchases of Investments | (310.4) | (712.0) | (224.9) | (148.5) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 506.2 | 279.0 | 185.6 | 78 | 0 | 0 | 0 |
| Other Investing Activities | (0.8) | 9.0 | 0 | (0.1) | (5) | 0.1 | 0 |
| Investing Cash Flow | 194.3 | (425.0) | (39.4) | (70.6) | (4.2) | (0.0) | (0.1) |
| Financing Activities | |||||||
| Net Debt Issuance | 19.8 | 0 | 24.7 | 19.8 | 4.9 | 5.5 | (0.2) |
| Stock Repurchased | 0 | (0.0) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (25.9) | (6.2) | (4.0) | (2.2) | (0.2) | 0.1 |
| Financing Cash Flow | 308.9 | 606.7 | 133.5 | 101.9 | 53.9 | 85.3 | (0.1) |
| Cash Position | |||||||
| Net Change in Cash | 262.1 | 47.0 | 1.9 | (36.2) | 26.0 | 50.4 | (10.6) |
| Cash at Beginning | 92.6 | 45.7 | 43.8 | 80.0 | 54.0 | 3.6 | 14.1 |
| Cash at End | 354.7 | 92.6 | 45.7 | 43.8 | 80.0 | 54.0 | 3.6 |
| Free Cash Flow | (241.7) | (135.7) | (92.2) | (67.7) | (23.7) | (34.9) | (10.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0.8 | 0 | (0.3) | (0.5) |
| Operating Income | (315.5) | (167.2) | (102.0) | (90.9) | (34.4) | (48.1) | (12.0) |
| Net Income | (299.6) | (152.1) | (96.0) | (89.1) | (32.6) | (53.4) | (11.9) |
| EPS (Diluted) | -4.66 | -2.75 | -2.25 | -3.35 | -2.43 | -14.40 | -3.46 |
| Balance Sheet | |||||||
| Cash & Equivalents | 354.7 | 92.6 | 45.7 | 43.5 | 79.7 | 53.7 | 3.2 |
| Total Assets | 734.7 | 655.7 | 175.5 | 131.4 | 83.7 | 54.6 | 5.4 |
| Total Debt | 77.3 | 54.6 | 53.7 | 31.3 | 4.9 | 0.0 | 0.1 |
| Stockholders' Equity | 604.5 | 577.2 | 101.7 | 76.9 | 69.6 | (89.3) | (36.5) |
| Cash Flow | |||||||
| Operating Cash Flow | (241.1) | (134.7) | (92.2) | (67.6) | (23.7) | (34.8) | (10.3) |
| Capital Expenditure | (0.6) | (1.0) | (0.1) | (0.1) | 0 | (0.1) | (0.1) |
| Free Cash Flow | (241.7) | (135.7) | (92.2) | (67.7) | (23.7) | (34.9) | (10.4) |